LOS ANGELES--(BUSINESS WIRE)--The Celiac Disease Foundation (CDF), a world leader in patient advocacy, and Takeda Development Center Americas (Takeda), a global biopharmaceutical leader, today are proud to announce the Celiac Disease Foundation–Takeda Early Career Research Award; an award designed to attract promising researchers to the study of celiac disease.
Through this unrestricted early-career research grant award, CDF and Takeda seek to encourage the development of individuals with research potential to help them prepare for a career of independent or clinical investigation in celiac disease. Stimulating and encouraging innovative research in the basic biomedical and clinical sciences will further understanding of the etiology, pathogenesis, therapy, and prevention of celiac disease. Collaborative efforts between basic scientists and clinicians are encouraged.
“The Celiac Disease Foundation is a global leader in accelerating research for celiac disease, and it is our core mission to compel funding that will lead to treatments and a cure,” said Marilyn G. Geller, Chief Executive Officer. “We greatly appreciate this partnership with Takeda to offer a new grant award that will not only advance our understanding of celiac disease and improve patients’ quality of life, but will also encourage continued progress and collaboration in the field of celiac disease research.”
“As a research-driven organization, Takeda is committed to celiac disease and supporting both new research and the development of scientific leaders who may advance our understanding of the condition,” said Nelson Cheinquer, Global Medical Affairs lead for Celiac Disease at Takeda. “We are proud to partner with the Celiac Disease Foundation to support the next generation of promising scientists and clinicians in the field.”
The award will provide $90,000 annually for the two-year funding period from September 2023-August 2025; the application deadline is August 1, 2023. Applicants must submit all required materials through the web-based CDF Grants Management System. A complete description of the award with application requirements can be found here.
About the Celiac Disease Foundation
The Celiac Disease Foundation is committed to driving diagnosis, treatments, and a cure for celiac disease. Since its founding in 1990, the Foundation has funded and executed international initiatives in three principal areas to bring an end to the suffering caused by celiac disease: medical research, patient and healthcare provider education, and public policy advocacy. As part of its dedicated, longstanding efforts to promote innovation in research, the Foundation has funded five Young Investigator Awards since 2017. In addition, the Foundation offers three annual international celiac disease research prizes: the Celiac Disease Foundation Prize for Excellence in Celiac Disease Research, the Young Investigator Prize for Basic Science, and the Young Investigator Prize for Clinical Science, all of which recognize researchers and clinician-scientists whose research has made a significant contribution to the field of celiac disease.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.